Merck & Co. Inc. buy Citigroup Inc.
Start price
05.02.25
/
50%
€86.00
Target price
05.02.26
€110.32
Performance (%)
0.83%
Price
18.12.25
€85.90
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Merck & Co. Inc. is nearly unchanged. Dividends of €0.81 are taken into consideration when calculating the performance. This prediction currently runs until 05.02.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 1.777% | 1.777% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Citigroup_Inc_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Citigroup Inc. from $125.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€93.60
28.01.25
28.01.25
€119.86
28.01.26
28.01.26
-7.36%
18.12.25
18.12.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€96.70
25.10.24
25.10.24
€120.32
25.10.25
25.10.25
-21.92%
26.10.25
26.10.25